APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical High-Performance Polymer

Compare research editions
View pricing & licenses

Selected research

Industry Research

Medical High-Performance Polymer Industry Research Report 2026

23 December 2025150 pages

Choose your research edition.

Industry ResearchMedical High-Performance Polymer Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical High-Performance Polymer Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Medical High-Performance Polymer Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical High-Performance Polymer Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical High-Performance Polymer Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Medical High-Performance Polymer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Medical High-Performance Polymer is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Medical High-Performance Polymer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Medical High-Performance Polymer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Medical High-Performance Polymer include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Medical High-Performance Polymer market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Medical High-Performance Polymer.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Medical High-Performance Polymer Market by Company

DuPont

BASF

Exxon Mobil

Victrex

TOPAS Advanced Polymers

Syensqo

Solvay

Saint-Gobain

SABIC

Röchling

RAUMEDIC

RadiciGroup

Mitsubishi Chemical

M2 Polymer Technologies

Evonik Industries

Ensinger

EMS-CHEMIE

Covestro

Celanese

CDI Products

Biesterfeld

Arkema

Medical High-Performance Polymer Segment by Type

Fluoropolymers

PPSU (polyphenylsulfone)

PEI (polyetherimide)

PEEK (polyetheretherketone)

Others

Medical High-Performance Polymer Segment by Application

Drug Delivery Systems

Dental Implants

Surgical Instruments

Orthopedic Implants

Catheters

Others

Medical High-Performance Polymer Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical High-Performance Polymer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical High-Performance Polymer and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical High-Performance Polymer.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Medical High-Performance Polymer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Medical High-Performance Polymer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Medical High-Performance Polymer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Medical High-Performance Polymer Production by Manufacturers (t) & (2021-2026) Table 6. Global Medical High-Performance Polymer Production Market Share by Manufacturers Table 7. Global Medical High-Performance Polymer Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Medical High-Performance Polymer Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Medical High-Performance Polymer Average Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Medical High-Performance Polymer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Medical High-Performance Polymer Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Medical High-Performance Polymer Manufacturers, Product Type & Application Table 13. Global Medical High-Performance Polymer Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical High-Performance Polymer by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. DuPont Company Information Table 18. DuPont Business Overview Table 19. DuPont Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 20. DuPont Medical High-Performance Polymer Product Portfolio Table 21. DuPont Recent Development Table 22. BASF Company Information Table 23. BASF Business Overview Table 24. BASF Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 25. BASF Medical High-Performance Polymer Product Portfolio Table 26. BASF Recent Development Table 27. Exxon Mobil Company Information Table 28. Exxon Mobil Business Overview Table 29. Exxon Mobil Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 30. Exxon Mobil Medical High-Performance Polymer Product Portfolio Table 31. Exxon Mobil Recent Development Table 32. Victrex Company Information Table 33. Victrex Business Overview Table 34. Victrex Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 35. Victrex Medical High-Performance Polymer Product Portfolio Table 36. Victrex Recent Development Table 37. TOPAS Advanced Polymers Company Information Table 38. TOPAS Advanced Polymers Business Overview Table 39. TOPAS Advanced Polymers Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 40. TOPAS Advanced Polymers Medical High-Performance Polymer Product Portfolio Table 41. TOPAS Advanced Polymers Recent Development Table 42. Syensqo Company Information Table 43. Syensqo Business Overview Table 44. Syensqo Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Syensqo Medical High-Performance Polymer Product Portfolio Table 46. Syensqo Recent Development Table 47. Solvay Company Information Table 48. Solvay Business Overview Table 49. Solvay Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 50. Solvay Medical High-Performance Polymer Product Portfolio Table 51. Solvay Recent Development Table 52. Saint-Gobain Company Information Table 53. Saint-Gobain Business Overview Table 54. Saint-Gobain Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 55. Saint-Gobain Medical High-Performance Polymer Product Portfolio Table 56. Saint-Gobain Recent Development Table 57. SABIC Company Information Table 58. SABIC Business Overview Table 59. SABIC Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 60. SABIC Medical High-Performance Polymer Product Portfolio Table 61. SABIC Recent Development Table 62. Röchling Company Information Table 63. Röchling Business Overview Table 64. Röchling Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 65. Röchling Medical High-Performance Polymer Product Portfolio Table 66. Röchling Recent Development Table 67. RAUMEDIC Company Information Table 68. RAUMEDIC Business Overview Table 69. RAUMEDIC Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. RAUMEDIC Medical High-Performance Polymer Product Portfolio Table 71. RAUMEDIC Recent Development Table 72. RadiciGroup Company Information Table 73. RadiciGroup Business Overview Table 74. RadiciGroup Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. RadiciGroup Medical High-Performance Polymer Product Portfolio Table 76. RadiciGroup Recent Development Table 77. Mitsubishi Chemical Company Information Table 78. Mitsubishi Chemical Business Overview Table 79. Mitsubishi Chemical Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 80. Mitsubishi Chemical Medical High-Performance Polymer Product Portfolio Table 81. Mitsubishi Chemical Recent Development Table 82. M2 Polymer Technologies Company Information Table 83. M2 Polymer Technologies Business Overview Table 84. M2 Polymer Technologies Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 85. M2 Polymer Technologies Medical High-Performance Polymer Product Portfolio Table 86. M2 Polymer Technologies Recent Development Table 87. Evonik Industries Company Information Table 88. Evonik Industries Business Overview Table 89. Evonik Industries Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 90. Evonik Industries Medical High-Performance Polymer Product Portfolio Table 91. Evonik Industries Recent Development Table 92. Ensinger Company Information Table 93. Ensinger Business Overview Table 94. Ensinger Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 95. Ensinger Medical High-Performance Polymer Product Portfolio Table 96. Ensinger Recent Development Table 97. EMS-CHEMIE Company Information Table 98. EMS-CHEMIE Business Overview Table 99. EMS-CHEMIE Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 100. EMS-CHEMIE Medical High-Performance Polymer Product Portfolio Table 101. EMS-CHEMIE Recent Development Table 102. Covestro Company Information Table 103. Covestro Business Overview Table 104. Covestro Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 105. Covestro Medical High-Performance Polymer Product Portfolio Table 106. Covestro Recent Development Table 107. Celanese Company Information Table 108. Celanese Business Overview Table 109. Celanese Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 110. Celanese Medical High-Performance Polymer Product Portfolio Table 111. Celanese Recent Development Table 112. CDI Products Company Information Table 113. CDI Products Business Overview Table 114. CDI Products Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 115. CDI Products Medical High-Performance Polymer Product Portfolio Table 116. CDI Products Recent Development Table 117. Biesterfeld Company Information Table 118. Biesterfeld Business Overview Table 119. Biesterfeld Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 120. Biesterfeld Medical High-Performance Polymer Product Portfolio Table 121. Biesterfeld Recent Development Table 122. Arkema Company Information Table 123. Arkema Business Overview Table 124. Arkema Medical High-Performance Polymer Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 125. Arkema Medical High-Performance Polymer Product Portfolio Table 126. Arkema Recent Development Table 127. Global Medical High-Performance Polymer Production Comparison by Region: 2021 VS 2025 VS 2032 (t) Table 128. Global Medical High-Performance Polymer Production by Region (2021-2026) & (t) Table 129. Global Medical High-Performance Polymer Production Market Share by Region (2021-2026) Table 130. Global Medical High-Performance Polymer Production Forecast by Region (2027-2032) & (t) Table 131. Global Medical High-Performance Polymer Production Market Share Forecast by Region (2027-2032) Table 132. Global Medical High-Performance Polymer Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Global Medical High-Performance Polymer Production Value by Region (2021-2026) & (US$ Million) Table 134. Global Medical High-Performance Polymer Production Value Market Share by Region (2021-2026) Table 135. Global Medical High-Performance Polymer Production Value Forecast by Region (2027-2032) & (US$ Million) Table 136. Global Medical High-Performance Polymer Market Average Price (USD/t) by Region (2021-2026) Table 137. Global Medical High-Performance Polymer Market Average Price (USD/t) by Region (2027-2032) Table 138. Global Medical High-Performance Polymer Consumption Comparison by Region: 2021 VS 2025 VS 2032 (t) Table 139. Global Medical High-Performance Polymer Consumption by Region (2021-2026) & (t) Table 140. Global Medical High-Performance Polymer Consumption Market Share by Region (2021-2026) Table 141. Global Medical High-Performance Polymer Forecasted Consumption by Region (2027-2032) & (t) Table 142. Global Medical High-Performance Polymer Forecasted Consumption Market Share by Region (2027-2032) Table 143. North America Medical High-Performance Polymer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 144. North America Medical High-Performance Polymer Consumption by Country (2021-2026) & (t) Table 145. North America Medical High-Performance Polymer Consumption by Country (2027-2032) & (t) Table 146. Europe Medical High-Performance Polymer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 147. Europe Medical High-Performance Polymer Consumption by Country (2021-2026) & (t) Table 148. Europe Medical High-Performance Polymer Consumption by Country (2027-2032) & (t) Table 149. Asia Pacific Medical High-Performance Polymer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 150. Asia Pacific Medical High-Performance Polymer Consumption by Country (2021-2026) & (t) Table 151. Asia Pacific Medical High-Performance Polymer Consumption by Country (2027-2032) & (t) Table 152. South America, Middle East & Africa Medical High-Performance Polymer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 153. South America, Middle East & Africa Medical High-Performance Polymer Consumption by Country (2021-2026) & (t) Table 154. South America, Middle East & Africa Medical High-Performance Polymer Consumption by Country (2027-2032) & (t) Table 155. Global Medical High-Performance Polymer Production by Type (2021-2026) & (t) Table 156. Global Medical High-Performance Polymer Production by Type (2027-2032) & (t) Table 157. Global Medical High-Performance Polymer Production Market Share by Type (2021-2026) Table 158. Global Medical High-Performance Polymer Production Market Share by Type (2027-2032) Table 159. Global Medical High-Performance Polymer Production Value by Type (2021-2026) & (US$ Million) Table 160. Global Medical High-Performance Polymer Production Value by Type (2027-2032) & (US$ Million) Table 161. Global Medical High-Performance Polymer Production Value Market Share by Type (2021-2026) Table 162. Global Medical High-Performance Polymer Production Value Market Share by Type (2027-2032) Table 163. Global Medical High-Performance Polymer Price by Type (2021-2026) & (USD/t) Table 164. Global Medical High-Performance Polymer Price by Type (2027-2032) & (USD/t) Table 165. Global Medical High-Performance Polymer Production by Application (2021-2026) & (t) Table 166. Global Medical High-Performance Polymer Production by Application (2027-2032) & (t) Table 167. Global Medical High-Performance Polymer Production Market Share by Application (2021-2026) Table 168. Global Medical High-Performance Polymer Production Market Share by Application (2027-2032) Table 169. Global Medical High-Performance Polymer Production Value by Application (2021-2026) & (US$ Million) Table 170. Global Medical High-Performance Polymer Production Value by Application (2027-2032) & (US$ Million) Table 171. Global Medical High-Performance Polymer Production Value Market Share by Application (2021-2026) Table 172. Global Medical High-Performance Polymer Production Value Market Share by Application (2027-2032) Table 173. Global Medical High-Performance Polymer Price by Application (2021-2026) & (USD/t) Table 174. Global Medical High-Performance Polymer Price by Application (2027-2032) & (USD/t) Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Medical High-Performance Polymer Distributors List Table 178. Medical High-Performance Polymer Customers List Table 179. Medical High-Performance Polymer Industry Trends Table 180. Medical High-Performance Polymer Industry Drivers Table 181. Medical High-Performance Polymer Industry Restraints Table 182. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Medical High-Performance Polymer Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Fluoropolymers Product Image Figure 7. PPSU (polyphenylsulfone) Product Image Figure 8. PEI (polyetherimide) Product Image Figure 9. PEEK (polyetheretherketone) Product Image Figure 10. Others Product Image Figure 11. Drug Delivery Systems Product Image Figure 12. Dental Implants Product Image Figure 13. Surgical Instruments Product Image Figure 14. Orthopedic Implants Product Image Figure 15. Catheters Product Image Figure 16. Others Product Image Figure 17. Global Medical High-Performance Polymer Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Medical High-Performance Polymer Production Value (2021-2032) & (US$ Million) Figure 19. Global Medical High-Performance Polymer Production Capacity (2021-2032) & (t) Figure 20. Global Medical High-Performance Polymer Production (2021-2032) & (t) Figure 21. Global Medical High-Performance Polymer Average Price (USD/t) & (2021-2032) Figure 22. Global Medical High-Performance Polymer Key Manufacturers, Manufacturing Sites & Headquarters Figure 23. Global Top 5 and 10 Medical High-Performance Polymer Players Market Share by Production Value in 2025 Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Medical High-Performance Polymer Production Comparison by Region: 2021 VS 2025 VS 2032 (t) Figure 26. Global Medical High-Performance Polymer Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Medical High-Performance Polymer Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Medical High-Performance Polymer Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Medical High-Performance Polymer Production Value (US$ Million) Growth Rate (2021-2032) Figure 30. Europe Medical High-Performance Polymer Production Value (US$ Million) Growth Rate (2021-2032) Figure 31. China Medical High-Performance Polymer Production Value (US$ Million) Growth Rate (2021-2032) Figure 32. Japan Medical High-Performance Polymer Production Value (US$ Million) Growth Rate (2021-2032) Figure 33. Global Medical High-Performance Polymer Consumption Comparison by Region: 2021 VS 2025 VS 2032 (t) Figure 34. Global Medical High-Performance Polymer Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 36. North America Medical High-Performance Polymer Consumption Market Share by Country (2021-2032) Figure 37. United States Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 38. United States Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 39. Canada Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 40. Mexico Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 41. Europe Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 42. Europe Medical High-Performance Polymer Consumption Market Share by Country (2021-2032) Figure 43. Germany Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 44. France Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 45. U.K. Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 46. Italy Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 47. Russia Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 48. Spain Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 49. Netherlands Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 50. Switzerland Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 51. Sweden Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 52. Poland Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 53. Asia Pacific Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 54. Asia Pacific Medical High-Performance Polymer Consumption Market Share by Country (2021-2032) Figure 55. China Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 56. Japan Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 57. South Korea Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 58. India Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 59. Australia Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 60. Taiwan Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 61. Southeast Asia Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 62. South America, Middle East & Africa Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 63. South America, Middle East & Africa Medical High-Performance Polymer Consumption Market Share by Country (2021-2032) Figure 64. Brazil Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 65. Argentina Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 66. Chile Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 67. Turkey Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 68. GCC Countries Medical High-Performance Polymer Consumption and Growth Rate (2021-2032) & (t) Figure 69. Global Medical High-Performance Polymer Production Market Share by Type (2021-2032) Figure 70. Global Medical High-Performance Polymer Production Value Market Share by Type (2021-2032) Figure 71. Global Medical High-Performance Polymer Price (USD/t) by Type (2021-2032) Figure 72. Global Medical High-Performance Polymer Production Market Share by Application (2021-2032) Figure 73. Global Medical High-Performance Polymer Production Value Market Share by Application (2021-2032) Figure 74. Global Medical High-Performance Polymer Price (USD/t) by Application (2021-2032) Figure 75. Medical High-Performance Polymer Value Chain Figure 76. Medical High-Performance Polymer Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Medical High-Performance Polymer Industry Opportunities and Challenges

Scope & coverage.

Types
  • Fluoropolymers
  • PPSU (polyphenylsulfone)
  • PEI (polyetherimide)
  • PEEK (polyetheretherketone)
  • Others
Applications
  • Drug Delivery Systems
  • Dental Implants
  • Surgical Instruments
  • Orthopedic Implants
  • Catheters
  • Others
Companies covered
  • DuPont
  • BASF
  • Exxon Mobil
  • Victrex
  • TOPAS Advanced Polymers
  • Syensqo
  • Solvay
  • Saint-Gobain
  • SABIC
  • Röchling
  • RAUMEDIC
  • RadiciGroup
  • Mitsubishi Chemical
  • M2 Polymer Technologies
  • Evonik Industries
  • Ensinger
  • EMS-CHEMIE
  • Covestro
  • Celanese
  • CDI Products
  • Biesterfeld
  • Arkema

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Medical High-Performance Polymer by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Fluoropolymers
  5. 2.2.3 PPSU (polyphenylsulfone)
  6. 2.2.4 PEI (polyetherimide)
  7. 2.2.5 PEEK (polyetheretherketone)
  8. 2.2.6 Others
  9. 2.3 Medical High-Performance Polymer by Application
  10. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  11. 2.3.2 Drug Delivery Systems
  12. 2.3.3 Dental Implants
  13. 2.3.4 Surgical Instruments
  14. 2.3.5 Orthopedic Implants
  15. 2.3.6 Catheters
  16. 2.3.7 Others
  17. 2.4 Global Market Growth Prospects
  18. 2.4.1 Global Medical High-Performance Polymer Production Value Estimates and Forecasts (2021-2032)
  19. 2.4.2 Global Medical High-Performance Polymer Production Capacity Estimates and Forecasts (2021-2032)
  20. 2.4.3 Global Medical High-Performance Polymer Production Estimates and Forecasts (2021-2032)
  21. 2.4.4 Global Medical High-Performance Polymer Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Medical High-Performance Polymer Production by Manufacturers (2021-2026)
  2. 3.2 Global Medical High-Performance Polymer Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Medical High-Performance Polymer Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Medical High-Performance Polymer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical High-Performance Polymer Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Medical High-Performance Polymer Manufacturers, Product Type & Application
  7. 3.7 Global Medical High-Performance Polymer Manufacturers Established Date
  8. 3.8 Global Medical High-Performance Polymer Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 DuPont
  2. 4.1.1 DuPont Medical High-Performance Polymer Company Information
  3. 4.1.2 DuPont Medical High-Performance Polymer Business Overview
  4. 4.1.3 DuPont Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 DuPont Product Portfolio
  6. 4.1.5 DuPont Recent Developments
  7. 4.2 BASF
  8. 4.2.1 BASF Medical High-Performance Polymer Company Information
  9. 4.2.2 BASF Medical High-Performance Polymer Business Overview
  10. 4.2.3 BASF Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 BASF Product Portfolio
  12. 4.2.5 BASF Recent Developments
  13. 4.3 Exxon Mobil
  14. 4.3.1 Exxon Mobil Medical High-Performance Polymer Company Information
  15. 4.3.2 Exxon Mobil Medical High-Performance Polymer Business Overview
  16. 4.3.3 Exxon Mobil Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Exxon Mobil Product Portfolio
  18. 4.3.5 Exxon Mobil Recent Developments
  19. 4.4 Victrex
  20. 4.4.1 Victrex Medical High-Performance Polymer Company Information
  21. 4.4.2 Victrex Medical High-Performance Polymer Business Overview
  22. 4.4.3 Victrex Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Victrex Product Portfolio
  24. 4.4.5 Victrex Recent Developments
  25. 4.5 TOPAS Advanced Polymers
  26. 4.5.1 TOPAS Advanced Polymers Medical High-Performance Polymer Company Information
  27. 4.5.2 TOPAS Advanced Polymers Medical High-Performance Polymer Business Overview
  28. 4.5.3 TOPAS Advanced Polymers Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 TOPAS Advanced Polymers Product Portfolio
  30. 4.5.5 TOPAS Advanced Polymers Recent Developments
  31. 4.6 Syensqo
  32. 4.6.1 Syensqo Medical High-Performance Polymer Company Information
  33. 4.6.2 Syensqo Medical High-Performance Polymer Business Overview
  34. 4.6.3 Syensqo Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Syensqo Product Portfolio
  36. 4.6.5 Syensqo Recent Developments
  37. 4.7 Solvay
  38. 4.7.1 Solvay Medical High-Performance Polymer Company Information
  39. 4.7.2 Solvay Medical High-Performance Polymer Business Overview
  40. 4.7.3 Solvay Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Solvay Product Portfolio
  42. 4.7.5 Solvay Recent Developments
  43. 4.8 Saint-Gobain
  44. 4.8.1 Saint-Gobain Medical High-Performance Polymer Company Information
  45. 4.8.2 Saint-Gobain Medical High-Performance Polymer Business Overview
  46. 4.8.3 Saint-Gobain Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Saint-Gobain Product Portfolio
  48. 4.8.5 Saint-Gobain Recent Developments
  49. 4.9 SABIC
  50. 4.9.1 SABIC Medical High-Performance Polymer Company Information
  51. 4.9.2 SABIC Medical High-Performance Polymer Business Overview
  52. 4.9.3 SABIC Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 SABIC Product Portfolio
  54. 4.9.5 SABIC Recent Developments
  55. 4.10 Röchling
  56. 4.10.1 Röchling Medical High-Performance Polymer Company Information
  57. 4.10.2 Röchling Medical High-Performance Polymer Business Overview
  58. 4.10.3 Röchling Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Röchling Product Portfolio
  60. 4.10.5 Röchling Recent Developments
  61. 4.11 RAUMEDIC
  62. 4.11.1 RAUMEDIC Medical High-Performance Polymer Company Information
  63. 4.11.2 RAUMEDIC Medical High-Performance Polymer Business Overview
  64. 4.11.3 RAUMEDIC Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 RAUMEDIC Product Portfolio
  66. 4.11.5 RAUMEDIC Recent Developments
  67. 4.12 RadiciGroup
  68. 4.12.1 RadiciGroup Medical High-Performance Polymer Company Information
  69. 4.12.2 RadiciGroup Medical High-Performance Polymer Business Overview
  70. 4.12.3 RadiciGroup Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 RadiciGroup Product Portfolio
  72. 4.12.5 RadiciGroup Recent Developments
  73. 4.13 Mitsubishi Chemical
  74. 4.13.1 Mitsubishi Chemical Medical High-Performance Polymer Company Information
  75. 4.13.2 Mitsubishi Chemical Medical High-Performance Polymer Business Overview
  76. 4.13.3 Mitsubishi Chemical Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  77. 4.13.4 Mitsubishi Chemical Product Portfolio
  78. 4.13.5 Mitsubishi Chemical Recent Developments
  79. 4.14 M2 Polymer Technologies
  80. 4.14.1 M2 Polymer Technologies Medical High-Performance Polymer Company Information
  81. 4.14.2 M2 Polymer Technologies Medical High-Performance Polymer Business Overview
  82. 4.14.3 M2 Polymer Technologies Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  83. 4.14.4 M2 Polymer Technologies Product Portfolio
  84. 4.14.5 M2 Polymer Technologies Recent Developments
  85. 4.15 Evonik Industries
  86. 4.15.1 Evonik Industries Medical High-Performance Polymer Company Information
  87. 4.15.2 Evonik Industries Medical High-Performance Polymer Business Overview
  88. 4.15.3 Evonik Industries Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  89. 4.15.4 Evonik Industries Product Portfolio
  90. 4.15.5 Evonik Industries Recent Developments
  91. 4.16 Ensinger
  92. 4.16.1 Ensinger Medical High-Performance Polymer Company Information
  93. 4.16.2 Ensinger Medical High-Performance Polymer Business Overview
  94. 4.16.3 Ensinger Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  95. 4.16.4 Ensinger Product Portfolio
  96. 4.16.5 Ensinger Recent Developments
  97. 4.17 EMS-CHEMIE
  98. 4.17.1 EMS-CHEMIE Medical High-Performance Polymer Company Information
  99. 4.17.2 EMS-CHEMIE Medical High-Performance Polymer Business Overview
  100. 4.17.3 EMS-CHEMIE Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  101. 4.17.4 EMS-CHEMIE Product Portfolio
  102. 4.17.5 EMS-CHEMIE Recent Developments
  103. 4.18 Covestro
  104. 4.18.1 Covestro Medical High-Performance Polymer Company Information
  105. 4.18.2 Covestro Medical High-Performance Polymer Business Overview
  106. 4.18.3 Covestro Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  107. 4.18.4 Covestro Product Portfolio
  108. 4.18.5 Covestro Recent Developments
  109. 4.19 Celanese
  110. 4.19.1 Celanese Medical High-Performance Polymer Company Information
  111. 4.19.2 Celanese Medical High-Performance Polymer Business Overview
  112. 4.19.3 Celanese Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  113. 4.19.4 Celanese Product Portfolio
  114. 4.19.5 Celanese Recent Developments
  115. 4.20 CDI Products
  116. 4.20.1 CDI Products Medical High-Performance Polymer Company Information
  117. 4.20.2 CDI Products Medical High-Performance Polymer Business Overview
  118. 4.20.3 CDI Products Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  119. 4.20.4 CDI Products Product Portfolio
  120. 4.20.5 CDI Products Recent Developments
  121. 4.21 Biesterfeld
  122. 4.21.1 Biesterfeld Medical High-Performance Polymer Company Information
  123. 4.21.2 Biesterfeld Medical High-Performance Polymer Business Overview
  124. 4.21.3 Biesterfeld Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  125. 4.21.4 Biesterfeld Product Portfolio
  126. 4.21.5 Biesterfeld Recent Developments
  127. 4.22 Arkema
  128. 4.22.1 Arkema Medical High-Performance Polymer Company Information
  129. 4.22.2 Arkema Medical High-Performance Polymer Business Overview
  130. 4.22.3 Arkema Medical High-Performance Polymer Production Capacity, Value and Gross Margin (2021-2026)
  131. 4.22.4 Arkema Product Portfolio
  132. 4.22.5 Arkema Recent Developments
5 Global Medical High-Performance Polymer Production by Region
  1. 5.1 Global Medical High-Performance Polymer Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Medical High-Performance Polymer Production by Region: 2021-2032
  3. 5.2.1 Global Medical High-Performance Polymer Production by Region: 2021-2026
  4. 5.2.2 Global Medical High-Performance Polymer Production Forecast by Region (2027-2032)
  5. 5.3 Global Medical High-Performance Polymer Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Medical High-Performance Polymer Production Value by Region: 2021-2032
  7. 5.4.1 Global Medical High-Performance Polymer Production Value by Region: 2021-2026
  8. 5.4.2 Global Medical High-Performance Polymer Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Medical High-Performance Polymer Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Medical High-Performance Polymer Production and Value, YOY Growth
  11. 5.6.1 North America Medical High-Performance Polymer Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Medical High-Performance Polymer Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Medical High-Performance Polymer Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Medical High-Performance Polymer Production Value Estimates and Forecasts (2021-2032)
6 Global Medical High-Performance Polymer Consumption by Region
  1. 6.1 Global Medical High-Performance Polymer Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical High-Performance Polymer Consumption by Region (2021-2032)
  3. 6.2.1 Global Medical High-Performance Polymer Consumption by Region: 2021-2026
  4. 6.2.2 Global Medical High-Performance Polymer Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical High-Performance Polymer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Medical High-Performance Polymer Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Medical High-Performance Polymer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Medical High-Performance Polymer Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Medical High-Performance Polymer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Medical High-Performance Polymer Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Medical High-Performance Polymer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Medical High-Performance Polymer Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Medical High-Performance Polymer Production by Type (2021-2032)
  2. 7.1.1 Global Medical High-Performance Polymer Production by Type (2021-2032) & (t)
  3. 7.1.2 Global Medical High-Performance Polymer Production Market Share by Type (2021-2032)
  4. 7.2 Global Medical High-Performance Polymer Production Value by Type (2021-2032)
  5. 7.2.1 Global Medical High-Performance Polymer Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Medical High-Performance Polymer Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Medical High-Performance Polymer Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Medical High-Performance Polymer Production by Application (2021-2032)
  2. 8.1.1 Global Medical High-Performance Polymer Production by Application (2021-2032) & (t)
  3. 8.1.2 Global Medical High-Performance Polymer Production Market Share by Application (2021-2032)
  4. 8.2 Global Medical High-Performance Polymer Production Value by Application (2021-2032)
  5. 8.2.1 Global Medical High-Performance Polymer Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Medical High-Performance Polymer Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Medical High-Performance Polymer Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Medical High-Performance Polymer Value Chain Analysis
  2. 9.1.1 Medical High-Performance Polymer Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Medical High-Performance Polymer Production Mode & Process
  5. 9.2 Medical High-Performance Polymer Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Medical High-Performance Polymer Distributors
  8. 9.2.3 Medical High-Performance Polymer Customers
10 Global Medical High-Performance Polymer Analyzing Market Dynamics
  1. 10.1 Medical High-Performance Polymer Industry Trends
  2. 10.2 Medical High-Performance Polymer Industry Drivers
  3. 10.3 Medical High-Performance Polymer Industry Opportunities and Challenges
  4. 10.4 Medical High-Performance Polymer Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst